Not many additions made since the last presentation but this is one of them.
"Discussions currently underway with many major companies and leading developers of drugs for Alzheimer’s disease".
DSMB #3 would have to be imminent. Considering treatment of 174 patients completed on the 26th of this month and all patients will be completed treatment on the 26th of next month I would assume this final safety assessment would incorporate 100% of patients. Might just be the catalyst to kick things off. Hopefully.
ACW Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
